Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELSA elobixibat stool bile acid study in chronic constipation
jRCTs031180035Completed
- Sponsor
- Applicable
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of elobixibat in chronic constipation (2 arms), sponsored by Applicable. Primary endpoint: Change in stool total bile acids after elobixibat treatment. Started Dec 2018; status: completed.
02
Drugs
elobixibat
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCTs031180035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180035.